Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
Reuterin-producing Lactobacillus brevis
US9387229B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9387229-B2 |
| Application number | US-201114361565-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 30, 2011 |
| Priority date | Nov 30, 2011 |
| Publication date | Jul 12, 2016 |
| Grant date | Jul 12, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to reuterin-producing strains of Lactobacillus brevis . These strains are useful in particular for the treatment or the prevention of conditions resulting from Helicobacter pylori infection.
First claim
Opening claim text (preview).
The invention claimed is: 1. A reuterin-accumulating Lactobacillus brevis strain that is the Lactobacillus brevis strain deposited with the CNCM (Collection Nationale De Cultures De Microorganismes) under Accession number I-4431. 2. A method of producing reuterin comprising the steps of: (a) culturing the Lactobacillus brevis strain of claim 1 under conditions sufficient to produce reuterin and (b) recovering the reuterin produced by the culture in step (a). 3. A nutritional composition comprising the Lactobacillus strain of claim 1 . 4. The composition according to claim 3 , comprising at least 10 5 cfu, per gram dry weight, of the Lactobacillus brevis strain. 5. The composition of claim 3 , wherein the composition is a dairy product. 6. The composition of claim 3 , wherein the composition is a fermented dairy product. 7. A pharmaceutical composition comprising the Lactobacillus brevis strain of claim 1 . 8. A method of treating an H. pylori infection in a subject in need thereof comprising administering to the subject the pharmaceutical composition according to claim 7 in an amount effective to treat the H. pylori infection. 9. The method of claim 8 , wherein the subject is suffering from a H. pylori infection.
Assignees
Inventors
Classifications
Antibacterial agents · CPC title
for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title
Bacteria or derivatives thereof, e.g. probiotics · CPC title
- A61K35/747Primary
Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9387229B2 cover?
- The invention relates to reuterin-producing strains of Lactobacillus brevis . These strains are useful in particular for the treatment or the prevention of conditions resulting from Helicobacter pylori infection.
- Who is the assignee on this patent?
- Garault Peggy, Quere Gaelle, Bourdet-Sicard Raphaelle, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K35/747. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).